Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss	$ (61,803)	$ (46,608)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,370	2,795
Accretion of marketable securities	(846)
Non-cash interest expense related to note payable	401	432
Stock-based compensation	4,312	2,367
Changes in current assets and liabilities:
Accounts receivable		(31,926)
Prepaid expenses and other assets	240	1,728
Right-of-use assets and lease liabilities, net	605	240
Accounts payable	(14)	862
Accrued expense and other liabilities	343	1,520
Deferred revenue	(1,100)	22,981
Net cash used in operating activities	(55,492)	(45,609)
Cash flows from investing activities:
Purchases of property and equipment	(1,567)	(1,258)
Purchases of marketable securities	(57,133)
Maturities of marketable securities	61,147
Net cash provided by (used in) investing activities	2,447	(1,258)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs	33,131	42,600
Proceeds from issuance of pre-funded warrants, net of offering costs	128,272	92,394
Proceeds from exercise of stock options	442	682
Net cash provided by financing activities	161,845	135,676
Net increase (decrease) in cash, cash equivalents and restricted cash	108,800	88,809
Cash, cash equivalents, and restricted cash - beginning of period	138,390	125,064
Cash, cash equivalents, and restricted cash - end of period	247,190	213,873
Summary of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:
Cash and cash equivalents	242,159	208,842
Restricted cash	5,031	5,031
Total cash, cash equivalents, and restricted cash	247,190	213,873
Supplemental disclosure of cash flow information:
Cash paid for interest	1,510	1,502
Supplemental disclosure of non-cash investing and financing activities:
Purchase of property and equipment in accounts payable and accrued liabilities	$ 977	87
Issuance costs included in accounts payable and accrued liabilities		$ 262